Mylan Pharmaceuticals ULC, in consultation with Health Canada, is voluntarily recalling one lot of Methotrexate Injection USP 50 mg/2 mL due to the potential presence of foreign particulate matter.
Pharmacist's team at British hospital wins $104,000 prize for bedside application that has significantly reduced high-risk, broad-spectrum antibiotic prescribing.